Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake. / Hagemann, Christoffer A.; Gasbjerg, Lærke S.; Christensen, Mikkel B.; Knop, Filip K.

I: STAR Protocols, Bind 4, Nr. 1, 102070, 2023.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Hagemann, CA, Gasbjerg, LS, Christensen, MB & Knop, FK 2023, 'Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake', STAR Protocols, bind 4, nr. 1, 102070. https://doi.org/10.1016/j.xpro.2023.102070

APA

Hagemann, C. A., Gasbjerg, L. S., Christensen, M. B., & Knop, F. K. (2023). Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake. STAR Protocols, 4(1), [102070]. https://doi.org/10.1016/j.xpro.2023.102070

Vancouver

Hagemann CA, Gasbjerg LS, Christensen MB, Knop FK. Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake. STAR Protocols. 2023;4(1). 102070. https://doi.org/10.1016/j.xpro.2023.102070

Author

Hagemann, Christoffer A. ; Gasbjerg, Lærke S. ; Christensen, Mikkel B. ; Knop, Filip K. / Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake. I: STAR Protocols. 2023 ; Bind 4, Nr. 1.

Bibtex

@article{432363905e554e27b0d7bfd9eb97cc26,
title = "Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake",
abstract = "Here, we present a protocol for a randomized, double-blind, placebo-controlled, crossover trial to evaluate the effects of a continuous intravenous infusion of a native liver-derived hormone, liver-expressed antimicrobial peptide 2 (LEAP2), on postprandial glucose metabolism, appetite and satiety sensations, and ad libitum food intake in humans. We describe the preparation of the exogenous hormone administration and participants. We then detail the liquid mixed meal, ad libitum meal test, and blood sampling procedures for assessing postprandial glucose metabolism and food intake. For complete details on the use and execution of this protocol, please refer to Hagemann et al. (2022).1",
keywords = "Behavior, Clinical Protocol, Metabolism",
author = "Hagemann, {Christoffer A.} and Gasbjerg, {L{\ae}rke S.} and Christensen, {Mikkel B.} and Knop, {Filip K.}",
note = "Publisher Copyright: {\textcopyright} 2023 The Author(s)",
year = "2023",
doi = "10.1016/j.xpro.2023.102070",
language = "English",
volume = "4",
journal = "STAR Protocols",
issn = "2666-1667",
publisher = "Cell Press",
number = "1",

}

RIS

TY - JOUR

T1 - Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake

AU - Hagemann, Christoffer A.

AU - Gasbjerg, Lærke S.

AU - Christensen, Mikkel B.

AU - Knop, Filip K.

N1 - Publisher Copyright: © 2023 The Author(s)

PY - 2023

Y1 - 2023

N2 - Here, we present a protocol for a randomized, double-blind, placebo-controlled, crossover trial to evaluate the effects of a continuous intravenous infusion of a native liver-derived hormone, liver-expressed antimicrobial peptide 2 (LEAP2), on postprandial glucose metabolism, appetite and satiety sensations, and ad libitum food intake in humans. We describe the preparation of the exogenous hormone administration and participants. We then detail the liquid mixed meal, ad libitum meal test, and blood sampling procedures for assessing postprandial glucose metabolism and food intake. For complete details on the use and execution of this protocol, please refer to Hagemann et al. (2022).1

AB - Here, we present a protocol for a randomized, double-blind, placebo-controlled, crossover trial to evaluate the effects of a continuous intravenous infusion of a native liver-derived hormone, liver-expressed antimicrobial peptide 2 (LEAP2), on postprandial glucose metabolism, appetite and satiety sensations, and ad libitum food intake in humans. We describe the preparation of the exogenous hormone administration and participants. We then detail the liquid mixed meal, ad libitum meal test, and blood sampling procedures for assessing postprandial glucose metabolism and food intake. For complete details on the use and execution of this protocol, please refer to Hagemann et al. (2022).1

KW - Behavior

KW - Clinical Protocol

KW - Metabolism

UR - http://www.scopus.com/inward/record.url?scp=85147261915&partnerID=8YFLogxK

U2 - 10.1016/j.xpro.2023.102070

DO - 10.1016/j.xpro.2023.102070

M3 - Journal article

C2 - 36853704

AN - SCOPUS:85147261915

VL - 4

JO - STAR Protocols

JF - STAR Protocols

SN - 2666-1667

IS - 1

M1 - 102070

ER -

ID: 335676267